A 62-year-old woman with long-standing type 2 diabetes and established coronary artery disease has HbA1c 7.5 percent despite maximally tolerated metformin. Estimated glomerular filtration rate is 55 mL/min/1.73 m², and BMI is 33 kg/m². According to Diabetes Canada, which additional agent is preferred for cardiorenal risk reduction?